AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06764355 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel 175 mg/m2, 3h-IVF, Q3W on day 1 for 2 cycles
Study NCT06764355 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin 75 mg/m2, 2h-IVF, Q3W on day 1 for 2 cycles
Study NCT06764355 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Description: Chemoradiotherapy~* Paclitaxel 50 mg/m2, 1h-IVF, on days 1, 8,15, 22, and 29;~* Cisplatin 30 mg/m2,1h-IVF, on days 1, 8,15, 22, and 29;~* RT: 1.8 Gy/fraction, 5 days a week, for 25 fractions (total dose= 45 Gy).
Study NCT06763003 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: The music therapy session described follows a structured and engaging approach, aimed at enhancing the patient's cognitive skills during neurorehabilitation. Here's a summary of the session components: Relaxation Phase, Song Selection, Instrument Selection and Familiarization, Rhythmic Training, Progression and Adjustment, Session Frequency and Customization. This individualized approach aims to enhance patient engagement and recovery by integrating music, rhythm, and therapeutic interaction into the neurorehabilitation process.
Study NCT06763003 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care (in control arm)
Description: In the control group, participants will receive the standard neurorehabilitation program prescribed by the rehabilitation team, without the addition of music therapy. This will provide a baseline to compare outcomes with the intervention group and evaluate the feasibility and preliminary effects of the music therapy intervention. The usual cognitive rehabilitation program during the subacute stroke period focuses on restoring cognitive abilities such as attention, memory, executive functions, and communication. The control group's daily rehabilitation sessions will last for 45 minutes, mirroring the music therapy group's session duration, ensuring a fair comparison of outcomes across both groups. This comparison will help assess the unique contributions of music therapy on cognitive functions like attention, memory, and executive functions in stroke patients.
Study NCT06762821 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single-visit revascularization
Description: Revascularization protocol will be performed in single visit
Study NCT06762821 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Multiple-visit revascularization
Description: Revascularization protocol will be performed in multiple visit
Study NCT06763822 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: close eyes
Description: ask participants to close their eyes for rest
Study NCT06763822 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: close eyes
Description: ask participants to close their eyes for rest
Study NCT06763822 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cold compress
Description: cold compress on participants' eyes for rest
Study NCT06763822 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: cold compress
Description: cold compress on participants' eyes for rest
Study NCT06764329 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mesenchymal Stem Cells
Description: allogeneic bone marrow-derived mesenchymal stem cells therapy
Study NCT06764329 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 0.9 % saline
Description: 0.9% Saline as placebo
Study NCT05550623 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tourniquet
Description: Tourniquet use in transfemoral amputation.
Study NCT06098118 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MyMammogram decision aid
Description: An online breast cancer screening decision aid that includes personalized risk assessment, information on benefits and risks of mammography screening, values clarification, outcome expectancies, and a summative document with participant responses.
Study NCT05467579 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Device: orthodontic - mandibular advancement clear aligner
Description: Intervention orthodontic - mandibular advancement: mandibular retrognathia correction with a mandibular advancement using a step-wise approach with clear aligner.
Study NCT05055921 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multi Pulse Therapy as delivered from the Cardialen External Stimulation System
Description: The Cardialen External Stimulation System (CESS) is the research delivery system for the proprietary Cardialen MultiPulse Therapy (MPT). The CESS is a custom designed and built research device. It is comprised of off-the-shelf commercial components (power supplies, waveform generators, laptop computer, monitor, rack, ECG system, leads, etc.) combined with a custom electrical circuit board and custom software.~Other Names:~* Unpinning Termination Therapy~* Multi-stage therapy~* Multi-stage electrotherapy~* MultiPulse Therapy
Study NCT05621642 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Breathing exercises
Description: In the sitting position, the patient does 15 diaphragm breathing and 15 huffing exercises.
Study NCT05621642 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breathing exercises
Description: In the sitting position, the patient does 15 diaphragm breathing and 15 huffing exercises.
Study NCT05621642 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Core stabilization exercises
Description: This intervention includes bridging exercise and abdominal exercises.
Study NCT05621642 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core stabilization exercises
Description: This intervention includes bridging exercise and abdominal exercises.
Study NCT05621642 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Balance and strengthening exercises
Description: It includes sitting and standing on the chair 15 times and turning around the chair.
Study NCT05467579 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Device: orthodontic - mandibular advancement clear aligner
Description: Intervention orthodontic - mandibular advancement: mandibular retrognathia correction with a mandibular advancement using a step-wise approach with clear aligner.
Study NCT05621642 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balance and strengthening exercises
Description: It includes sitting and standing on the chair 15 times and turning around the chair.
Study NCT06502600 — intervention group
Intervention type: PROCEDURE
Intervention: surgery time
Description: This study is a retrospective observational study, with surgery time being one of the exposure factors under investigation.
Study NCT06502600 — intervention group
Intervention type: PROCEDURE
Intervention: surgeon
Description: This study is a retrospective observational study, with surgeon being one of the exposure factors under investigation.
Study NCT06502600 — intervention group
Intervention type: PROCEDURE
Intervention: surgical procedure duration
Description: This study is a retrospective observational study, with surgical procedure duration being one of the exposure factors under investigation.
Study NCT06502600 — intervention group
Intervention type: PROCEDURE
Intervention: operating room
Description: This study is a retrospective observational study, with surgical procedure duration being one of the exposure factors under investigation.
Study NCT06502600 — intervention group
Intervention type: PROCEDURE
Intervention: type of surgery
Description: This study is a retrospective observational study, with type of surgery being one of the exposure factors under investigation.
Study NCT06403163 — intervention group
Intervention type: PROCEDURE
Intervention: Transfusion
Description: Transfusion of an hemostatic product
Study NCT05256654 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3561774
Description: Administered SC
Study NCT05256654 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC
Study NCT06053099 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plasma ctDNA
Description: * Plasma ctDNA before surgery (optional)~* Plasma ctDNA post-surgery : 4 to 8 weeks post-surgery, before starting adjuvant chemotherapy (if given) and before starting adjuvant osimertinib (if given)~* Plasma ctDNA every 6 months~* Plasma ctDNA at relapse
Study NCT06053099 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FFPE blocks
Description: * Surgery FFPE blocks~* FFPE blocks at relapse (optional)
Study NCT05737056 — intervention group
Intervention type: OTHER
Intervention: Management of rheumatoid purpura
Description: Collection of data on the management in pediatric emergency departments (method of diagnosis, complementary examinations, proposed treatment, number of hospitalizations, follow-up after hospital discharge).
Study NCT05538962 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Sensor skin
Description: Skin sensor to detect inflammatory molecules in sweat
Study NCT05144932 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stroke Alarm
Description: The patients are in this clinical trial instructed to use the device continuously for 1 month.
Study NCT05242497 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pharmacopuncture
Description: This is a pragmatic randomized controlled trials, so the physicians will choose pharmacopuncture treatment, including the type and doses, according to each participant's conditions. The researcher will record the specific intervention precisely and concurrently.
Study NCT05242497 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: conservative treatments (including physiotherapy)
Description: This is a pragmatic randomized controlled trials, so the physicians will choose conservative treatment, including physiotherapy and pharmacological treatment, according to each participant's conditions. The researcher will record the specific intervention precisely and concurrently.
Study NCT06144710 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SG301 SC Injection
Description: Subcutaneous injection every two weeks
Study NCT06144710 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SG301 SC Injection
Description: Subcutaneous injection every two weeks
Study NCT06144710 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SG301 SC Placebo
Description: Subcutaneous injection every two weeks
Study NCT05013151 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dates
Description: Consumption of 6 dates a days until 41 weeks of gestation
Study NCT05013151 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Castor oil
Description: One time consumption of 60 CC Castor oil
Study NCT05907213 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine (Ketalar) Dose Level 1
Description: Loading Dose: 0.05 mg/kg/hr X 1 hour; Maintenance Dose 0.05 mg/kg/hr x 12 hours
Study NCT05907213 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine (Ketalar) Dose Level 2
Description: Loading Dose: 0.08 mg/kg/hr X 1 hour; Maintenance Dose 0.05 mg/kg/hr x 12 hours
Study NCT05907213 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine (Ketalar) Dose Level 3
Description: Loading Dose: 0.12 mg/kg/hr X 1 hour; Maintenance Dose 0.05 mg/kg/hr x 12 hours
Study NCT05907213 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine (Ketalar) Dose Level 4
Description: Loading Dose: 0.18 mg/kg/hr X 1 hour; Maintenance Dose 0.05 mg/kg/hr x 12 hours
Study NCT06426108 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluoride Varnishes
Description: the investigators will utilize a fluoride varnish with a concentration of 22,600 ppm F. The application will be facilitated using a microbrush, ensuring thorough coverage over the entire length of the lesion for a duration of 30 seconds. Following application, the varnish will be finished with water to create a film on the tooth surface. After completing the interventions, patients will receive instructions to refrain from consuming hard foods and to postpone tooth brushing for at least four hours, adhering to the manufacturer's recommendations.
Study NCT06426108 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluoride Varnishes
Description: the investigators will utilize a fluoride varnish with a concentration of 22,600 ppm F. The application will be facilitated using a microbrush, ensuring thorough coverage over the entire length of the lesion for a duration of 30 seconds. Following application, the varnish will be finished with water to create a film on the tooth surface. After completing the interventions, patients will receive instructions to refrain from consuming hard foods and to postpone tooth brushing for at least four hours, adhering to the manufacturer's recommendations.
Study NCT06426108 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Varnishes placebo
Description: the investigators will apply a placebo varnish without the active ingredient (fluoride), ensuring that it is packaged identically to the fluoride varnish and has the same taste and texture, thus maintaining consistency in application. The varnish will be applied using a microbrush, spreading it evenly over the entire length of the lesion for a duration of 30 seconds. Following the interventions, patients will receive instructions to avoid consuming hard foods and to delay tooth brushing for at least four hours after applying the varnish.
Study NCT06426108 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Varnishes placebo
Description: the investigators will apply a placebo varnish without the active ingredient (fluoride), ensuring that it is packaged identically to the fluoride varnish and has the same taste and texture, thus maintaining consistency in application. The varnish will be applied using a microbrush, spreading it evenly over the entire length of the lesion for a duration of 30 seconds. Following the interventions, patients will receive instructions to avoid consuming hard foods and to delay tooth brushing for at least four hours after applying the varnish.
Study NCT06426108 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Low-Intensity Laser 1J
Description: The tooth will undergo low-intensity laser irradiation in continuous mode, employing a wavelength of 808 nm, a power output of 100 mW, a dose of 1 Joule, and a fluence of 35 J/cm\^2. The laser will be positioned perpendicular to the tooth surface, targeting the cervical third of the buccal surface (both mesial and distal aspects), as well as the center of the lesion.
Study NCT06426108 — intervention group
Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Low-Intensity Laser 1J
Description: The tooth will undergo low-intensity laser irradiation in continuous mode, employing a wavelength of 808 nm, a power output of 100 mW, a dose of 1 Joule, and a fluence of 35 J/cm\^2. The laser will be positioned perpendicular to the tooth surface, targeting the cervical third of the buccal surface (both mesial and distal aspects), as well as the center of the lesion.
Study NCT06426108 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Low-Intensity Laser 2J
Description: The tooth will undergo low-intensity laser irradiation in continuous mode, employing a wavelength of 808 nm, a power output of 100 mW, a dose of 2 Joules, and a fluence of 35 J/cm\^2. The laser will be positioned perpendicular to the tooth surface, targeting the cervical third of the buccal surface (both mesial and distal aspects), as well as the center of the lesion.
Study NCT06426108 — intervention group
Intervention type: RADIATION
Group type: SHAM_COMPARATOR
Intervention: Low-Intensity Laser 2J
Description: The tooth will undergo low-intensity laser irradiation in continuous mode, employing a wavelength of 808 nm, a power output of 100 mW, a dose of 2 Joules, and a fluence of 35 J/cm\^2. The laser will be positioned perpendicular to the tooth surface, targeting the cervical third of the buccal surface (both mesial and distal aspects), as well as the center of the lesion.
Study NCT06493032 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gastric Alimetry System
Description: medical device that uses a large sheet of electrodes to assess gastric motility
Study NCT05067595 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Description: Undergo lower FMT via colonoscopy
Study NCT05067595 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation
Description: Given upper FMT PO
Study NCT05067595 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation
Description: Undergo lower FMT via colonoscopy
Study NCT05067595 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nutritional Supplementation
Description: Given dietary fiber supplementation PO
Study NCT05067595 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies
Study NCT05067595 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo tissue, stool, stool swabs, and blood sample collection
Study NCT06138249 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D
Description: Vitamin D
Study NCT05485363 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ultrasonographic measurement of the optic nerve sheath diameter
Description: Assessing the optic nerve sheath diameter as an indicator of intracranial pressure during different positions and on specific time intervals in patients undergoing laparoscopic sleeve gastrectomy
Study NCT06523569 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remote patient monitoring (RPM) system
Description: As a part of the bundled digital health intervention, the participant will be given a Bluetooth-enabled remote patient monitoring system.
Study NCT06523569 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile health application
Description: As a part of the bundled digital health intervention, the participant will be given a lifestyle change mobile health application.
Study NCT05764616 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PARASTERNAL BLOCK
Description: After induction of general anesthesia, an ultrasound-guided Parasternal Block will be performed with 20 mL of ropivacaine 0.5 % per side.
Study NCT05764616 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PARASTERNAL BLOCK
Description: After induction of general anesthesia, an ultrasound-guided Parasternal Block will be performed with 20 mL of ropivacaine 0.5 % per side.
Study NCT05764616 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: LOCAL INFILTRATION OF DRAINAGE EXIT SITES
Description: At the end of surgery, a local infiltration of drainage exit sites will be performed with 10 mL of ropivacaine 0.25% per side
Study NCT05764616 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: RECTUS SHEATH BLOCK
Description: At the end of surgery, a rectus sheath block will be performed with 10 mL of ropivacaine 0.25% per side.
Study NCT04166344 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Happyair Ecosystem
Description: Happyair Ecosystem is a Smart Community for the integral care of patients with chronic or rare respiratory diseases such as Asthma, COPD or Alfa-1.~Our community provides online \& offline training and resources in digital health and social care to patients, family, caregivers, healthcare professionals and researchers.~Using our platform, all of our members will be able to connect in order to improve the health and well-being of patients, learn to manage self-care, ensure an active lifestyle, and contribute to the development of current and future research projects.
Study NCT03962244 — intervention group
Intervention type: DEVICE
Intervention: EsoSponge
Description: Endoscopically placed an EsoSponge for Negative pressure wound therapy in the area of the esophagogastric anastomotic leaks
Study NCT03962244 — intervention group
Intervention type: DEVICE
Intervention: Self-Expanding Metal Stent
Description: Endoscopically placed self-expanding-metal-stent (SEMS) for negative pressure wound therapy in the area of the esophagogastric anastomotic leaks
Study NCT05912140 — intervention group
Intervention type: OTHER
Intervention: TRACE 2
Description: The first version of TRACE2 will be retrospectively verified through its application by experts on 150 photos of scoliosis patients who agreed to use the material produced for clinical use for retrospective research. Both intra-operator and inter-operator repeatability will be evaluated and a first Rasch analysis will be performed.~The new version of TRACE2 (TRACE2.2) obtained following the retrospective validation on the photos will be verified prospectively through its application by the experts on 150 patients in specialist medical examination. Both intra-operator and inter-operator repeatability will be evaluated and further Rasch analysis will follow. On the basis of the results obtained from the analysis, the new TRACE2 scale (TRACE2.3) will then be applied to a further 150 patients, its intra- and inter-operator repeatability will be calculated and a final Rasch analysis will be performed to arrive at the final version of the scale (TRACE2.4).
Study NCT04745949 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brentuximab Vedotin
Description: Given IV
Study NCT04745949 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT04745949 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Description: Given IV
Study NCT04745949 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV
Study NCT04745949 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Given PO
Study NCT04745949 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04745949 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Given IV